BUSINESS NEWS
Pfizer to buy Array Biopharma for $48 a share in cash
[ad_1]
Pfizer has agreed to acquire Array Biopharma for approximately $11.4 billion in cash, including debt.
Shares of Array Biopharma soared 59% in premarket trading on the news.
The boards of directors of both companies have approved the merger.
This is breaking news. Please check back for updates.
[ad_2]
Source link